Your browser doesn't support javascript.
loading
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis.
Ntaios, George; Swaminathan, Balakumar; Berkowitz, Scott D; Gagliardi, Rubens José; Lang, Wilfried; Siegler, James E; Lavados, Pablo; Mundl, Hardi; Bornstein, Natan; Meseguer, Elena; Amarenco, Pierre; Cucchiara, Brett; Camps-Renom, Pol; Makaritsis, Konstantinos; Korompoki, Eleni; Papavasileiou, Vasileios; Marti-Fabregas, Joan; Milionis, Haralampos; Vemmos, Konstantinos; Connolly, Stuart J; Hart, Robert G.
Afiliação
  • Ntaios G; From the Department of Internal Medicine, University of Thessaly, Larissa, Greece (G.N., K.M.).
  • Swaminathan B; Population Health Research Institute, Hamilton, ON, Canada (B.S.).
  • Berkowitz SD; Bayer US LLC, Pharmaceuticals Clinical Development Thrombosis, NJ (S.D.B.).
  • Gagliardi RJ; Irmandade da Santa Casa de Misericórdia de São Paulo, Brazil (R.J.G.).
  • Lang W; Hospital St John of God, Sigmund Freud Private University, Medical Faculty, Vienna, Austria (W.L.).
  • Siegler JE; Department of Neurology, Hospital of the University of Pennsylvania (J.E.S., B.C.).
  • Lavados P; Clínica Alemana de Santiago, Santiago, Chile (P.L.).
  • Mundl H; Bayer AG, Wuppertal, Germany (H.M.).
  • Bornstein N; Shaare-Zedek Medical Center Jerusalem, Israel (N.B.).
  • Meseguer E; Neurology Service, Bichat Hospital, Paris, France (E.M.).
  • Amarenco P; APHP, Bichat hospital, Paris-Diderot, Sorbonne Paris Cité university, France (P.A.).
  • Cucchiara B; Department of Neurology, Hospital of the University of Pennsylvania (J.E.S., B.C.).
  • Camps-Renom P; Unitat de Malalties Vasculars Cerebrals, Servei de Neurologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (P.C.-R., J.M.-R.).
  • Makaritsis K; From the Department of Internal Medicine, University of Thessaly, Larissa, Greece (G.N., K.M.).
  • Korompoki E; Division of Brain Science, Imperial College London, Charing Cross Hospital, United Kingdom (E.K.).
  • Papavasileiou V; Department of Clinical Therapeutics, University Athens School of Medicine, Greece (E.K.).
  • Marti-Fabregas J; Stroke Medicine, Leeds Teaching Hospitals NHS Trust, School of Medicine, University of Leeds, West Yorkshire, United Kingdom (V.P.).
  • Milionis H; Unitat de Malalties Vasculars Cerebrals, Servei de Neurologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (P.C.-R., J.M.-R.).
  • Vemmos K; School of Health Sciences, Faculty of Medicine University of Ioannina, Greece (H.M.).
  • Connolly SJ; Hellenic Cardiovascular Research Society, Athens, Greece (K.V.).
  • Hart RG; Department of Medicine, (Cardiology) Population Health Research Institute, McMaster University, Hamilton, ON, Canada. (S.J.C.).
Stroke ; 50(9): 2477-2485, 2019 09.
Article em En | MEDLINE | ID: mdl-31401971
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças das Artérias Carótidas / Aspirina / Acidente Vascular Cerebral / Embolia Intracraniana / Rivaroxabana Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças das Artérias Carótidas / Aspirina / Acidente Vascular Cerebral / Embolia Intracraniana / Rivaroxabana Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2019 Tipo de documento: Article